AMERICAN INTERNATIONAL GROUP, INC. - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$573,720
+6.9%
28,000
+3.7%
0.00%
+33.3%
Q2 2023$536,589
+16.2%
27,005
+0.2%
0.00%0.0%
Q1 2023$461,602
-7.2%
26,947
+6.0%
0.00%0.0%
Q4 2022$497,430
+49.8%
25,418
+22.3%
0.00%
+50.0%
Q3 2022$332,000
+17.7%
20,775
+1.4%
0.00%0.0%
Q2 2022$282,000
-13.2%
20,482
+0.1%
0.00%0.0%
Q1 2022$325,000
-32.0%
20,471
-6.6%
0.00%0.0%
Q4 2021$478,000
-28.2%
21,910
-1.6%
0.00%
-50.0%
Q3 2021$666,000
-32.5%
22,277
+0.1%
0.00%
+33.3%
Q2 2021$986,000
+2.0%
22,259
+2.1%
0.00%0.0%
Q1 2021$967,000
-11.0%
21,792
+10.1%
0.00%
-25.0%
Q4 2020$1,086,000
+133.0%
19,801
-2.8%
0.00%
+100.0%
Q3 2020$466,000
+6.9%
20,369
-2.2%
0.00%0.0%
Q2 2020$436,000
+64.5%
20,833
+9.9%
0.00%
+100.0%
Q1 2020$265,000
-37.5%
18,963
+1.8%
0.00%
-50.0%
Q4 2019$424,000
+93.6%
18,621
-0.8%
0.00%
+100.0%
Q3 2019$219,000
-22.9%
18,778
-0.7%
0.00%0.0%
Q2 2019$284,000
+7.2%
18,909
+25.0%
0.00%0.0%
Q1 2019$265,000
+29.9%
15,131
+10.1%
0.00%0.0%
Q4 2018$204,000
-40.2%
13,740
-0.8%
0.00%0.0%
Q3 2018$341,000
+27.7%
13,847
+1.8%
0.00%0.0%
Q2 2018$267,00013,5960.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,037,486$280,250,00019.13%
TANG CAPITAL MANAGEMENT LLC 2,965,485$52,015,0009.58%
Boxer Capital, LLC 1,466,051$25,715,0002.97%
Ghost Tree Capital, LLC 600,000$10,524,0002.75%
BRIDGER MANAGEMENT, LLC 1,529,032$26,819,0002.12%
Cormorant Asset Management, LP 1,700,000$29,818,0002.02%
EcoR1 Capital, LLC 450,000$7,893,0000.73%
UNIVERSITY OF NOTRE DAME DU LAC 171,015$3,000,0000.67%
Virtus ETF Advisers LLC 17,799$312,0000.66%
SPHERA FUNDS MANAGEMENT LTD. 290,001$5,087,0000.46%
View complete list of ROCKET PHARMACEUTICALS INC shareholders